ATTBF Stock UPDATES Abattis Bioceuticals (ATTBF) 0.4000 09/09/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Abattis Bioceuticals (ATTBF) 0.4000 $ATTBF

Abattis' Phytalab Receives Cannabis Lab Certification in Washington
ACCESSWIRE - Mon Sep 08, 7:07AM CDT
Vancouver, BC / ACCESSWIRE / September 8th, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Phytalytics LLC. ("Phytalab.com" , its 51% controlled US subsidiary, has received provisional certification from the Washington State Liquor Control Board. This milestone enables the lab to legally offer service to the new legal Cannabis industry.

Abattis Announces Grant of Stock Options
ACCESSWIRE - Wed Aug 13, 7:43PM CDT
Vancouver, BC / ACCESSWIRE / August 13, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), the Company is pleased to announce that, in compliance with the Company's option plan, the Company has granted 455,000 incentive stock options to certain of its directors, officers and consultants, with each option being exercisable into a common share of Abattis at $0.43 per share for a period of five years.

Abattis Appoints Jason Anderson as VP of Finance
ACCESSWIRE - Fri Aug 08, 3:47PM CDT
Vancouver, BC / ACCESSWIRE / August 8, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, patented equipment, and consulting services to medicinal markets in North American, today announced the appointment of Jason Anderson, CA, CFA as Vice President of Finance.

Abattis' Biocube Licenses Terrasphere Vertical Farming Technology
ACCESSWIRE - Wed Aug 06, 8:07AM CDT
Vancouver, BC / ACCESSWIRE / August 6, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Biocube Green Grow Systems Corp. ("Biocube" , its wholly owned subsidiary, entered into a worldwide non-exclusive licensing agreement with TerraSphere Systems LLC ("TerraSphere" for the company's proprietary and patented vertical farming technology. The TerraSphere license complements Biocube's previously announced sublicensing agreement for Vertical Design Ltd.'s ("VDL" vertical farming technology.

Abattis Enters Into US$5 Million Standby Equity Purchase Agreement with Kodiak Capital Group, LLC
ACCESSWIRE - Tue Aug 05, 8:11AM CDT
Vancouver, BC / ACCESSWIRE / August 5, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, including medical marihuana, announced that it has entered into a US$5 million standby equity financing agreement with Kodiak Capital Group, LLC, a Newport Beach, CA-based institutional investor. The Company has agreed to file a registration statement with the U.S. Securities & Exchange Commission ("SEC" covering the Abattis shares that may be issued to Kodiak under this financing. After the SEC has declared the registration statement related to the transaction effective, the Company has the right at its sole discretion over a period of one year to sell up to US$5 million of common shares to Kodiak.

Abattis Sub-Licenses Vertical Grow Systems to Biocube
ACCESSWIRE - Thu Jul 31, 7:04AM CDT
Vancouver, BC / ACCESSWIRE / July 31, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), today announced that it has entered into a sub-licensing agreement with its subsidiary, Biocube Green Grow Systems Corp. ("Biocube" , for the non-exclusive use of Vertical Design Ltd.'s ("VDL" vertical growing systems for which Abattis owns certain exclusive worldwide rights. Under the terms of the agreement, Biocube has agreed to pay Abattis certain licensing fees and ongoing royalties for products grown and sold within the pharmaceutical, nutraceutical, cosmetic, and wellness markets. The company also wishes to clarify recent confusion about the ownership of the rights and uses to the VDL growing technology that has been created by Affinor Growers, (CSE: AFI) (OTCQB: RSSFF) the parent of VDL.

Abattis Makes History as First Marijuana Stock to List on Prestigious OTCQX
ACCESSWIRE - Tue Jul 15, 7:00AM CDT
Whitefish, MT / July 15, 2014 / Abattis Bioceuticals Corp. (OTC: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary products and services to the North American cannabis industry, added to its growing list of accomplishments by becoming the first cannabis stock to list on the prestigious OTCQX tier of the OTC Markets on Monday, July 14, 2014.

Cannabis Stocks Move Higher as Washington State Pot Sales Begin
ACCESSWIRE - Mon Jul 14, 8:30AM CDT
WHITEFISH, MT / July 14, 2014 / The Marijuana Index(TM) moved higher last week in the aggregate, despite a 13% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares and a roughly 1.5% drop in Medbox Inc. (OTC: MDBX) shares, which comprise about half of the weighted index.

Abattis Begins Trading On The OTCQX
ACCESSWIRE - Mon Jul 14, 5:17AM CDT
Vancouver, BC / ACCESSWIRE / July 14, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that it began trading on the OTCQX marketplace.

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX®
PR Newswire - Fri Jul 11, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that Abattis Bioceuticals Corp. (CSE: ATT; OTCQX: ATTBF), a specialty biotechnology company, has qualified to trade on OTCQX®, the best marketplace.

Abattis Information Available on S&P Capital IQ
ACCESSWIRE - Mon Jul 07, 12:21AM CDT
Vancouver, BC / ACCESSWIRE / July 6, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio---similar compounds, equipment, and consulting services to North American medicinal markets, today announced that its company information would be made available via S&P Capital IQ Corporation Record's Listing Program. This is one of the final steps in the Company elevating to the OTC QX in the upcoming months.

Correction To Earlier News: Abattis Names Brazos Minshew The Next President Of Biocell
ACCESSWIRE - Wed Jul 02, 10:53PM CDT
Vancouver, BC / ACCESSWIRE / July 02, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Brazos Minshew, Chief Executive Officer of Samuel J. Brant, LLC and would like to issue the following correction.

Abattis Names Brazos Minshew The Next President Of Biocell
ACCESSWIRE - Wed Jul 02, 7:23PM CDT
Vancouver, BC / ACCESSWIRE / July 02, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Brazos Minshew, Chief Executive Officer of Samuel J. Brant, LLC, former Chief Science Officer of TriVita, Inc., former Chief Executive Officer of Therapy Alternatives and Director of Marketing for Tiena Health, will assume the role of President of BioCell Labs, a wholly-owned subsidiary of Abattis Bioceuticals Corp. effective July 1, 2014. He will succeed Mike Withrow, who is resigning his role of President at BioCell to focus on leadership as Chief Executive Officer of Abattis Bioceuticals Corp. He will remain as Chairman of BioCell.

Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.

Abattis Bioceuticals to be Featured on CEO Clips Airing on BNN
ACCESSWIRE - Fri Jun 27, 3:55PM CDT
Vancouver, BC / ACCESSWIRE / June 27, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC Pink: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that CEO Clips will be running a series of commercials on Canada's Business News Network ("BNN" advertising the Company's upcoming BTV Business Television segment are to be shown on July 19th and July 20th.

Abattis Bioceuticals Receives Breakthrough Nitric Oxide WIPO Patent Publication
ACCESSWIRE - Mon Jun 23, 4:57PM CDT
Vancouver, BC / ACCESSWIRE / June 23, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC Pink: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that its wholly-owned subsidiary, BioCell Laboratories, Inc. ("BioCell" , was awarded an International Patent for refining the optimum natural sources of nitric oxide in the human body.

Abattis Bioceuticals Adopts New Policies, Changes Auditor & Adds New Board Members at Annual General Meeting of Shareholders
ACCESSWIRE - Thu Jun 19, 9:34PM CDT
Vancouver, BC / ACCESSWIRE/ June 19, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC Pink: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that its previous Board has been re-elected and two industry experts have been added to the Company's Board of Directors and shareholders have also approved the adoption of new policies at the Company's Annual General Meeting of Shareholders ("AGM" held on June 18, 2014.

Novus (NDEV) Aims to Fill Key Void in Cannabis Industry
ACCESSWIRE - Mon Jun 16, 7:04AM CDT
Whitefish, MT / June 16, 2014 / The U.S. legal cannabis industry is expected to reach $2.34 billion in size by the end of the year, according to ArcView Market Research. With additional states expected to legalize the drug over the next five years, the same group believes that the U.S. industry could reach $10.2 billion in size by 2018. These growth rates have attracted both investors and lawmakers interested in shoring up tax revenue.

Abattis Launches a New Corporate Website
ACCESSWIRE - Fri Jun 13, 3:38PM CDT
Vancouver, BC / ACCESSWIRE / June 13, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced the launch of its newly redesigned corporate website.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 27

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Arbor Realty Trust Faces Securities Fraud Allegations

Updated Category News Views 33

Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...

Continue Reading
Xiong'an New Area: People's Priorities Reshape Living Spaces

Updated Category News Views 278

Building a City for the People This here is about prioritizing people over skylines. Xiong'an New Area in Hebei Province is shaping up to be more than just a place on the map; it's an experiment in redefining urban living. Skyscrapers and traffic jams? Not on this menu. Instead, nature paves a graceful dance floor between mid-rise residences. Forget your bustling city...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 14

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 147

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 202

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Tackling the Industrialized Beast of Insurance Fraud

Updated Category News Views 86

Stepping Up the Fraud Fight This year's emerging fraud trends are taking the term 'organized crime' to new heights, and it's painting a bullseye on the insurance industry. The National Insurance Crime Bureau (NICB) just laid out how fraud isn't just a series of isolated scams anymore—it's an industrial-scale racket. As they spotlight during International Fraud Awareness...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 16

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Nasdaq Tumbles: AI Hardware Pulls Markets Down

Updated Category News Views 114

Wall Street's Slide Fueled by AI Nerves The markets got a real jolt on Monday, sending Nasdaq down 2.5% thanks to a sharp dip in AI hardware stocks. Tech tickers tied to artificial intelligence were at the core of a sell-off, knocking the S&P 500 down 1.92% alongside it. Investors are on edge, and it’s not just the weather—it's a real shake-up driven by policy moves...

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 80

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading

Top 5 Most Recently Viewed Articles

Sotelix Endoscopy Secures $1.7 Million to Innovate Gastro Care

Updated Category News Views 167

Sotelix Endoscopy Secures $1.7 Million in Seed Funding Sotelix Endoscopy, a forward-thinking medical device startup, has recently completed a successful seed round financing, raising an impressive $1.7 million. With this funding, the company will accelerate its research and development of next-generation therapeutic endoscopy devices, which are designed to significantly...

Continue Reading
TriplePoint Venture Growth BDC Faces Market Turbulence

Updated Category News Views 68

Challenges Faced by TriplePoint Venture Growth BDC Corp. In today's ever-shifting market landscape, TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) stock has recently reached a troubling 52-week low, settling at $6.59. This dramatic downturn is the result of investor caution, mirroring a significant 1-year shift of -31.5% in the company's valuation. Specializing in...

Continue Reading
Dave Aronberg Launches New Law Firm, Aims to Make an Impact

Updated Category News Views 349

Dave Aronberg Launches New Law Firm In an exciting new chapter, Dave Aronberg, a well-respected figure in the legal realm, has taken a significant step forward by establishing his own law firm. Having dedicated over two decades as a public servant, Aronberg will now lead a boutique firm specializing in both civil and criminal litigation, as well as land use planning. New...

Continue Reading
2026 Agricultural Outlook: A Dramatic Shift in Farmer Sentiment

Updated Category News Views 163

Shifting Emotions in Agriculture: January 2026 Overview Farmer sentiment has fallen significantly as we step into 2026, reflecting increasing economic anxieties. The recent Ag Economy Barometer, a vital measure of agricultural optimism, showed a considerable drop of 23 points from December to a reading of 113. This downturn points to a growing sense of disillusionment...

Continue Reading
Mattamy Homes Launches Exciting New Community in Goodyear

Updated Category News Views 339

Mattamy Homes Unveils New Community in Goodyear Mattamy Homes proudly announces the grand opening of its latest community, Las Ventanas, in one of the fastest-growing suburban areas. This exciting development offers 18 innovative and unique floor plans designed to meet the needs of modern families. Discover the Las Ventanas Community Las Ventanas represents the commitment...

Continue Reading